Palisade Bio (PALI) Total Debt Growth (1y) (2014 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 5.94% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 103.99% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.07% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -55.70% |
| Mar 31, 2025 | -51.75% |
| Dec 31, 2021 | -92.38% |
| Mar 31, 2017 | -63.91% |
| Dec 31, 2016 | -53.26% |
| Sep 30, 2016 | -46.83% |
| Jun 30, 2016 | -34.26% |
| Mar 31, 2016 | -21.07% |
| Dec 31, 2015 | -9.77% |
| Sep 30, 2015 | 247.82% |
| Jun 30, 2015 | 41.05% |
| Mar 31, 2015 | 26.15% |
| Dec 31, 2014 | 14.15% |
| Sep 30, 2014 | -62.55% |
| Jun 30, 2014 | -16.20% |
| Mar 31, 2014 | -6.76% |